Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Biomarker Pilot Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer

NCT03691311 is registered in ClinicalTrials.gov with Institut Català d'Oncologia as lead sponsor.

NCT NCT03691311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03691311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Biomarker Pilot Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer
Lead sponsor
Institut Català d'Oncologia
Phase
Phase 1
Overall status
Unknown status
Start date
July 5, 2018
Completion date
February 5, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female, hormone receptor negative neoplasm, hormone receptor positive tumor, stage i breast cancer, stage ii breast cancer